Suppr超能文献

总结慢性阻塞性肺疾病肺量计调查的已发表结果:定义不一致的问题。

Summarising published results from spirometric surveys of COPD: the problem of inconsistent definitions.

作者信息

Gupta R P, Perez-Padilla R, Marks G, Vollmer W, Menezes A, Burney P

机构信息

Respiratory Epidemiology and Public Health, National Heart and Lung Institute, Imperial College, London, UK.

Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.

出版信息

Int J Tuberc Lung Dis. 2014 Aug;18(8):998-1003. doi: 10.5588/ijtld.13.0910.

Abstract

SETTING

The use of different spirometric definitions for chronic obstructive pulmonary disease (COPD) has made an informative review of the available prevalence surveys impossible.

OBJECTIVE

To derive adjustment factors that allow the comparison of studies using different spirometric criteria.

METHODS

Pre- and post-bronchodilator one-second forced expiratory volume (FEV1) and forced vital capacity (FVC) values were taken from the Burden of Obstructive Lung Disease (BOLD) survey in 16 centres. Using a post-bronchodilator FEV1/FVC ratio less than the lower limit of normal (LLN) as our reference prevalence, we calculated simple multiplicative adjustments to transform other reported prevalence estimates to reference values. These adjustments were then tested on independent data sets from six further BOLD centres and five centres from the PLATINO study, a Latin American survey on obstructive lung disease.

RESULTS

Prevalence estimates based on pre-bronchodilator fixed-ratio measurements were 5-25% higher than reference values, and were strongly positively biased with age and prevalence level. Applying simple adjustments provided prevalence estimates that were almost unbiased and within 5% of the reference values.

CONCLUSIONS

Using the BOLD data, we have been able to estimate COPD prevalences based on post-bronchodilator FEV1/FVC < LLN by adjusting estimates based on other common definitions, enabling more meaningful comparisons of published findings.

摘要

背景

对慢性阻塞性肺疾病(COPD)使用不同的肺量计定义使得对现有患病率调查进行信息丰富的综述变得不可能。

目的

得出调整因子,以便能够对使用不同肺量计标准的研究进行比较。

方法

支气管扩张剂使用前后的一秒用力呼气容积(FEV1)和用力肺活量(FVC)值取自16个中心的慢性阻塞性肺疾病负担(BOLD)调查。以支气管扩张剂使用后FEV1/FVC比值低于正常下限(LLN)作为我们的参考患病率,我们计算了简单的乘法调整,以将其他报告的患病率估计值转换为参考值。然后在另外六个BOLD中心和拉丁美洲阻塞性肺疾病调查PLATINO研究的五个中心的独立数据集中对这些调整进行测试。

结果

基于支气管扩张剂使用前固定比值测量的患病率估计值比参考值高5%-25%,并且与年龄和患病率水平呈强烈正偏差。应用简单调整后得出的患病率估计值几乎无偏差,且在参考值的5%以内。

结论

利用BOLD数据,我们能够通过调整基于其他常见定义的估计值,基于支气管扩张剂使用后FEV1/FVC<LLN来估计COPD患病率,从而使已发表研究结果的比较更有意义。

相似文献

引用本文的文献

1
Chronic obstructive pulmonary disease in sub-Saharan Africa.撒哈拉以南非洲的慢性阻塞性肺疾病。
Int J Tuberc Lung Dis. 2022 Mar 1;26(3):232-242. doi: 10.5588/ijtld.21.0394.

本文引用的文献

7
Global burden of COPD: systematic review and meta-analysis.慢性阻塞性肺疾病的全球负担:系统评价与荟萃分析。
Eur Respir J. 2006 Sep;28(3):523-32. doi: 10.1183/09031936.06.00124605. Epub 2006 Apr 12.
9
10
Airway effects of salmeterol in healthy individuals.沙美特罗对健康个体气道的影响。
Pulm Pharmacol. 1995 Dec;8(6):283-8. doi: 10.1006/pulp.1995.1038.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验